We suggest that CD5+ DLBCL is a distinct immunophenotypic subtype, and its pathogenesis and biologic nature are possibly related to alternative activation of MYC or BCL2 proteins other than gene rearrangement. Here, CD5 is linked to diffuse large B-cell lymphoma.